Skip to main content
Clinical Trials/CTRI/2022/11/047705
CTRI/2022/11/047705Not yet recruiting未知

A randomised standard controlled clinical trial to evaluate the efficacy of Doorvadya Taila in the management of Atopic Dermatitis in children

PDEAs College of Ayurved and Research centre,sec no 25 Pradhikaran Nigdi, Pune 4110440 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patient having two or more following symptoms-1 Dry skin, Itching, Erythema, Burning sensation, Discharge .
  • 2 Children between the age group of 1 year to 12 year irrespective of gender, socioeconomic status and food habits.

Exclusion Criteria

  • 1 Weeping eczema, infected lesions will be excluded from the study
  • 2 Children having any other associated illness like diarrhea, acute respiratory infections, and acute febrile and other disorder will be excluded from the study
  • 3 Lichenified skin changes.
  • 4 Lesions greater than 9% body surface area.
  • 5 Suspected patient of Covid 19.

Investigators

Sponsor
PDEAs College of Ayurved and Research centre,sec no 25 Pradhikaran Nigdi, Pune 411044

Similar Trials